Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series
Sign Up to like & getrecommendations! Published in 2020 at "International Ophthalmology"
DOI: 10.1007/s10792-020-01501-6
Abstract: Purpose To present 11 bodybuilding athletes who developed central serous chorioretinopathy (CSCR) following high-dose subcutaneous follistatin-344, a peptide-based performance and image enhancing drug, injections to increase muscle mass. Methods This is a retrospective case series… read more here.
Keywords: dose follistatin; high dose; central serous; history ... See more keywords